Global investment firm KKR buys Danish biotech firm share for USD 100m

Nordic Bioscience's owner group has sold a minority stake in the company to global investment company KKR for USD 100m.

Nordic Bioscience owner group members Claus and Bente Christiansen | Photo: Steen Wrem/ERH

For the first time, the owners of Nordic Bioscience have opted to sell out of the biotech company. US investment company KKR has acquired a minority share in the Danish company, according to a KKR and Nordic Bioscience press announcement in which they mention neither the size nor the proportional share of the invested sum.

According to Danish newspaper Børsen, however, the invested figure is in the region of USD 100m.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs